These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 30968766
1. 2,4-Thiazolidinediones as PTP 1B Inhibitors: A Mini Review (2012-2018). Verma SK, Yadav YS, Thareja S. Mini Rev Med Chem; 2019; 19(7):591-598. PubMed ID: 30968766 [Abstract] [Full Text] [Related]
3. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review. Verma M, Gupta SJ, Chaudhary A, Garg VK. Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717 [Abstract] [Full Text] [Related]
4. 3D-QSAR studies on a series of 2,4-thiazolidinedione derivatives: a self- organizing molecular field analysis approach to design novel PTP 1B inhibitors. Malla P, Kumar M. Med Chem; 2013 Sep; 9(6):828-45. PubMed ID: 22974292 [Abstract] [Full Text] [Related]
8. The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity. Rocha RF, Rodrigues T, Menegatti ACO, Bernardes GJL, Terenzi H. Bioorg Chem; 2020 Jul 15; 100():103927. PubMed ID: 32422389 [Abstract] [Full Text] [Related]
9. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells. Ottanà R, Maccari R, Mortier J, Caselli A, Amuso S, Camici G, Rotondo A, Wolber G, Paoli P. Eur J Med Chem; 2014 Jan 15; 71():112-27. PubMed ID: 24287560 [Abstract] [Full Text] [Related]
10. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors. Mahapatra MK, Kumar R, Kumar M. Bioorg Chem; 2017 Apr 15; 71():1-9. PubMed ID: 28126289 [Abstract] [Full Text] [Related]
11. Self-organizing molecular field analysis of 2,4-thiazolidinediones: A 3D-QSAR model for the development of human PTP1B inhibitors. Thareja S, Aggarwal S, Bhardwaj TR, Kumar M. Eur J Med Chem; 2010 Jun 15; 45(6):2537-46. PubMed ID: 20236737 [Abstract] [Full Text] [Related]
12. Design and synthesis of paracaseolide A analogues as selective protein tyrosine phosphatase 1B inhibitors. Yin JP, Tang CL, Gao LX, Ma WP, Li JY, Li Y, Li J, Nan FJ. Org Biomol Chem; 2014 Jun 07; 12(21):3441-5. PubMed ID: 24752625 [Abstract] [Full Text] [Related]
13. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors. Forghieri M, Laggner C, Paoli P, Langer T, Manao G, Camici G, Bondioli L, Prati F, Costantino L. Bioorg Med Chem; 2009 Apr 01; 17(7):2658-72. PubMed ID: 19297174 [Abstract] [Full Text] [Related]
15. Rosiglitazone attenuates tumor necrosis factor-α-induced protein-tyrosine phosphatase-1B production in HepG2 cells. Wu J, Yang LJ, Zou DJ. J Endocrinol Invest; 2012 Jan 01; 35(1):28-34. PubMed ID: 21483233 [Abstract] [Full Text] [Related]
16. Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes. Qian S, Zhang M, He Y, Wang W, Liu S. Future Med Chem; 2016 Jul 01; 8(11):1239-58. PubMed ID: 27357615 [Abstract] [Full Text] [Related]